Insmed Growth Agent iPlex Joins Tercica's Increlex With Orphan Drug Designation
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approves iPlex for the same indication as Increlex, but both products are granted orphan drug exclusivity.